“Our study confirmed that PICCs are strongly associated with DVT in upper limbs. However, what is novel and noteworthy in this study is that the presence of a PICC was also associated with an increased risk of lower-extremity DVT,” said Vineet Chopra, MD, the lead investigator and professor at the University of Michigan School of Medicine and the Michigan Hospital Medicine Safety Consortium.
Researchers studied 76,242 patients in 48 Michigan hospitals to review PICC placement, existing medical conditions, blood clot risk factors and thrombotic events within 90 days of hospitalization. Of the patients studied, 3,790 received a PICC.
Of those, there were 876 thromboembolic events, including 208 upper-extremity DVTs, 372 lower-extremity DVTs and 296 pulmonary emboli. Compared to patients who did not receive a PICC, the risk of developing a lower-extremity DVT was nearly 50 percent higher for patients who did receive a PICC.
Additionally, the researchers found that taking drugs to prevent a DVT did not reduce the risk of developing a DVT.
More articles on blood clots:
Dr. Peter Pronovost: Dangerous blood clots tend to fly ‘under the radar’ in hospitals
10 ways hospitals are making surgeries safer
Johns Hopkins: Blood clot penalties may be unfairly imposed
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.